Smith Cynthia
SEC insider (Form 3/4/5 filer). CIK 0001609480. Director at Spero Therapeutics, Inc. (SPRO) and 4 other issuers. 15 reported Form 4/5 transactions since Sep 2024; latest on Jun 23, 2026. Located in SUGAR LAND, TX.
Companies Smith Cynthia has filed insider reports for
- Spero Therapeutics, Inc. (SPRO): Director
- AGIOS PHARMACEUTICALS, INC. (AGIO): Director
- Akebia Therapeutics, Inc. (AKBA): Director
- Protara Therapeutics, Inc. (TARA): Director
- Tvardi Therapeutics, Inc. (TVRD): Director
Smith Cynthia
CIK: 0001609480
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (15 total)
- Jun 23, 2026SPRO
Spero Therapeutics, Inc.
AwardDirect10K shares- - Jun 18, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
AwardDirectRestricted stock units
2.9K shares- - Jun 18, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
ExerciseDirect2.8K shares- - Jun 18, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
AwardDirectStock options (right to buy)
15K shares- - Jun 17, 2026AKBA
Akebia Therapeutics, Inc.
AwardDirect35.7K shares- - Jun 15, 2026TARA
Protara Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
31K shares- - Jun 9, 2026TVRD
Tvardi Therapeutics, Inc.
AwardDirectStock Option (right to buy)
6K shares- - Aug 11, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
ExerciseDirect2.3K shares- - Jun 20, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
ExerciseDirect2.1K shares- - Jun 18, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
AwardDirectRestricted stock units
2.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 23, 2026 |  SPRO Spero Therapeutics, Inc. | Award | 10,000 | - | $0 | Direct |
| Jun 18, 2026 |  AGIO AGIOS PHARMACEUTICALS, INC. | Award Restricted stock units | 2,927 | - | - | Direct |
| Jun 18, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise | 2,816 | - | $0 | Direct |
| Jun 18, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Award Stock options (right to buy) | 14,950 | - | - | Direct |
| Jun 17, 2026 |  AKBA Akebia Therapeutics, Inc. | Award | 35,700 | - | $0 | Direct |
| Jun 15, 2026 |  TARA Protara Therapeutics, Inc. | Award Stock Option (Right to Buy) | 31,000 | - | - | Direct |
| Jun 9, 2026 |  TVRD Tvardi Therapeutics, Inc. | Award Stock Option (right to buy) | 6,000 | - | - | Direct |
| Aug 11, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise | 2,302 | - | - | Direct |
| Jun 20, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise | 2,120 | - | - | Direct |
| Jun 18, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Award Restricted stock units | 2,816 | - | - | Direct |
1-10 of 15 transactions